Carcinoma: all 6,718 studies

Page 27 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.

• Expression Analysis of the COPB 2 and Bcl-2 in Early Stages of Endometrial CarcinomaCompletedNCT05951426
• Prognostic Immune Biomarkers in HNSCCCompletedNCT05941676
• Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck CancerCompletedNCT05936502
• OT-101 in Combination With Atezolizumab for the Treatment of Metastatic or Recurrent Non-Small Cell Lung CancerWithdrawnNCT05935774Phase 2
• Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)TerminatedNCT05935748Phase 2
• Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and NeckTerminatedNCT05930951Phase 1
• Cadonilimab Plus TACE in Patients With Intermediate-stage Unresectable Hepatocellular CarcinomaActive, not recruitingNCT05925413Phase 2
• Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing RadiotherapyCompletedNCT05918224Phase 2
• Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft RejectionStatus unknownNCT05913583
• Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid TumorsTerminatedNCT05909995Phase 1
• Circulating Biomarkers in Oropharyngeal CancersActive, not recruitingNCT05904327
• Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular CarcinomaActive, not recruitingNCT05901194Phase 1/2
• Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular CarcinomaActive, not recruitingNCT05889949
• Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+TWithdrawnNCT05886257Phase 2
• Dose Optimized BNCT for Head and Neck CancerActive, not recruitingNCT05883007Phase 1
• A Phase 1 Clinical Study of NXP900 in Subjects With Advanced CancersActive, not recruitingNCT05873686Phase 1
• Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal CarcinomaActive, not recruitingNCT05869227Phase 3
• A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid TumorsActive, not recruitingNCT05867303Phase 1
• A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal CarcinomaCompletedNCT05864924Phase 1
• The Comparison Between HepaSphere Drug-eluting Bead Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular CarcinomaStatus unknownNCT05862181
• Evaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell CarcinomaCompletedNCT05861778Phase 1
• Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous CarcinomaStatus unknownNCT05854030
• BCC Excision RevisitedCompletedNCT05853315
• Paraneoplastic Syndrome in Hepatocellular Carcinoma PatientsStatus unknownNCT05846035
• Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell CarcinomaActive, not recruitingNCT05845632
• Single-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular CarcinomaTerminatedNCT05845502Not applicable
• Surgeon-performed Intraoperative Transoral Ultrasound for Cancer of Unknown PrimaryCompletedNCT05841966Not applicable
• Prognostic Models for HCC Based on Tumor MicronecrosisStatus unknownNCT05837065
• Patients with Stage III-IVa Nasopharyngeal Carcinoma with or Without a Mobile Medical Platform Full-course Nutritional InterventionCompletedNCT05834712Not applicable
• Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.Status unknownNCT05832593
• Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial CarcinomaStatus unknownNCT05823246Phase 2
• Salivary LINC00657 as a Diagnostic Biomarker for Oral Squamous Cell CarcinomaCompletedNCT05821179
• Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision TherapeuticsTerminatedNCT05819827
• Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell CarcinomaStatus unknownNCT05816642Not applicable
• A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid TumorsActive, not recruitingNCT05812027
• Immunohistochemical Evaluation of DNA Methylation and Histone Modification in H. Pylori Associated Gastric CarcinomaStatus unknownNCT05811546
• NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHNCompletedNCT05802290Phase 3
• Prognostic Role of HVPG and ICG-R15 in the Short- and Medium-term Results of the Surgery of HCC on CirrhosisStatus unknownNCT05800561
• European Multicenter Study on Surgical Management of Advanced Thyroid CancerStatus unknownNCT05796960
• A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid TumorsCompletedNCT05795595Phase 1/2
• Immunohistochemical Expression of Inhibin Beta A (INHBA) in Colorectal CarcinomaStatus unknownNCT05794737
• European Multicentric Study on Parathyroid CarcinomaStatus unknownNCT05789680
• A Study of CDX-585 in Patients With Advanced MalignanciesCompletedNCT05788484Phase 1
• Study to Assess the Feasibility in Bile cfDNA of Resectable Biliary Tract CarcinomasStatus unknownNCT05783973
• A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal CancerTerminatedNCT05780736
• Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal CarcinomaStatus unknownNCT05777707Phase 1/2
• Implantable Microdevice for TNBC - Pilot StudyWithdrawnNCT05774886Phase 1
• Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)TerminatedNCT05770882Phase 1/2
• European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical CarcinomaStatus unknownNCT05763524
• Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and TransareolaCompletedNCT05760690Not applicable
• Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+TStatus unknownNCT05760599Phase 2
• The Synergistic Effect of Portal Venous Supply Control and Immunotherapy in Hepatocellular CarcinomaStatus unknownNCT05760430Phase 2
• Zimberelimab Plus Metformin for Recurrent Ovarian Clear Cell CarcinomaStatus unknownNCT05759312Phase 1/2
• FMT in IT-refractory HCC - FAB-HCC Pilot StudyCompletedNCT05750030Phase 2
• A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell CarcinomaStatus unknownNCT05749042Phase 2
• Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHNWithdrawnNCT05743270Phase 2
• Low Grade Serous Ovarian Carcinoma and Uterine Involvement : Should Hysterectomy be the RuleCompletedNCT05741554
• Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal CarcinomaCompletedNCT05741008Not applicable
• Surgical Margin Assessment by 3D UltrasoundStatus unknownNCT05740774Not applicable
• HCC Staging Modified by Tumor MicronecrosisCompletedNCT05739110
• Diagnostic Accuracy of APAC, ASAP and GALAD Scores in Hepatocellular Carcinoma Among Cirrhotic PatientsStatus unknownNCT05738772
• Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular CarcinomaStatus unknownNCT05738447Phase 1
• Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial CarcinomaWithdrawnNCT05738161Phase 1
• The Role of 5% Lidocaine Patches in the Pain Control of Hepatocellular Carcinoma Patients Receiving Radiofrequency AblationCompletedNCT05732181Not applicable
• PAtient-PHYsician Relationship AssessmentCompletedNCT05729230
• Cemiplimab/Peg-Interferon-α in Advanced CSCCWithdrawnNCT05729139Phase 1
• A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell CarcinomaCompletedNCT05728515Early Phase 1
• Neoadjuvant Tislelizumab in Combination With Dasatinib and Quercetin in Resectable HNSCC (COIS-01)Active, not recruitingNCT05724329Phase 2
• Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and NeckActive, not recruitingNCT05721755Phase 3
• ALBI and PALBI Scores and HCC PrognosisCompletedNCT05720195
• Utility of Abbreviated Magnetic Resonance Imaging as a Screening Tool for Hepatocellular Carcinoma in Cirrhotic PatientsStatus unknownNCT05716620
• Epiction of the Genomic and Genetic Landscape Identifies CCL5 as a Protective Factor in Colorectal Neuroendocrine CarcinomaCompletedNCT05714722
• PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian CarcinomaWithdrawnNCT05714306Phase 1/2
• Proof of Concept Study to Access Superficial Basal Cell Carcinoma in AdultsCompletedNCT05713760Phase 2
• Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial CancerWithdrawnNCT05712941Phase 3
• A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)CompletedNCT05708950Phase 1/2
• The Long Non Coding MALAT1 as a Potential Salivary Diagnostic Biomarker in Oral Squamous Cell Carcinoma Through Targeting mi RNA 124CompletedNCT05708209
• SOGUG-AVELUMAB_RWDCompletedNCT05700344
• Galectin-3 in Papillary Thyroid CarcinomaStatus unknownNCT05699590
• A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder CancerTerminatedNCT05699135
• PDL1 In Primary Colorectal Carcinoma and Its Prognostic ImpactStatus unknownNCT05692895
• Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.TerminatedNCT05687617Phase 2
• Outcome of Laparoscopic Total Mesorectal Excision Versus Open Technique in Management of Rectal CarcimomaStatus unknownNCT05685680Not applicable
• Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver CarcinomaCompletedNCT05681234Not applicable
• A Phase 1b Study of WU-NK-101 in Combination With CetuximabActive, not recruitingNCT05674526Phase 1
• Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer SurvivorsWithdrawnNCT05672342Early Phase 1
• Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian CancerWithdrawnNCT05672095Phase 1/2
• the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine CarcinomaCompletedNCT05671393
• Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular CarcinomaStatus unknownNCT05670561Phase 4
• GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescence PCR Method)Status unknownNCT05668793
• Adrenal Vein Sampling as a Tool to Identify Biomarkers That Aid the Diagnosis of Adrenocortical CarcinomaStatus unknownNCT05660889
• Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT）Status unknownNCT05650216Phase 2
• Peri-operative Vitamin D Therapy for HepatectomyStatus unknownNCT05650151Not applicable
• Post-Operative Radiotherapy De-Escalation of Negative Nodal Regions in Head and Neck Squamous Cell CarcinomaStatus unknownNCT05650034Not applicable
• Mentored Community Gardening for Individuals With Skin CancerCompletedNCT05648604Not applicable
• Safety and Feasibility of Radioembolization Using Ho-166 in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT05643391Not applicable
• Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung CancerSuspendedNCT05642195Phase 1/2
• Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After PancreatoduodenectomyStatus unknownNCT05641233Phase 1/2
• Efficacy and Safety of Transarterial Therapies+Donafenib + Anti-PD-1 Antibody for uHCC: A Retrospective Real-world StudyStatus unknownNCT05638438
• Artificial Intelligence and Hepatocellular CarcinomaActive, not recruitingNCT05637788

← Carcinoma overview